Skip to search formSkip to main contentSkip to account menu

1 ML pasireotide 0.3 MG/ML Injection

Known as: pasireotide (as pasireotide diaspartate) 0.3 MG per 1 ML Injection, PASIREOTIDE 0.3MG/ML SOLN INJ, pasireotide 0.3 MG in 1 ML Injection 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (1)

HORMONES/SYNTHETICS/MODIFIERS,OTHER
InjectionSomatostatinanalogs & derivativespasireotide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Budget impact of pasireotide LAR for the treatment of acromegaly, a rare endocrine disorder
Abstract Background: Acromegaly is a rare disorder characterized by the over-production of growth hormone (GH). Patients often… 
2012
2012
Effetti di pasireotide nella malattia di Cushing: studio di fase 3 a 12 mesi
A. Colao, S. Petersenn, J. Newell-Price, J.W. Findling, F. Gu, M. Maldonado, U. Schoenherr, D. Mills, L.R. Salgado, B.M.K. Biller… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)